Why we need guidelines for clinical trials in vasculitis and systemic lupus erythematosus
AUTOR(ES)
Mukhtyar, Chetan
FONTE
BMJ Group
RESUMO
See linked article, p 605
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=1954609Documentos Relacionados
- Lupus anticoagulants in systemic lupus erythematosus: prevalence and clinical associations.
- EULAR recommendations for conducting clinical studies and/or clinical trials in systemic vasculitis: focus on anti‐neutrophil cytoplasm antibody‐associated vasculitis
- Systemic lupus erythematosus in men: clinical and immunological characteristics.
- Upregulated expression and function of integrin adhesive receptors in systemic lupus erythematosus patients with vasculitis.
- Systemic lupus erythematosus in the elderly: clinical and immunological characteristics.